Low Dose Cyclophosphamide in Combination with Elotuzumab - a Novel Immunotherapeutic Strategy for Multiple Myeloma

被引：0
|
作者：
Feerick, Claire L. [1 ,2 ,3 ]
Lynch, Kevin [2 ,3 ,4 ]
Krawczyk, Janusz [2 ,5 ,6 ]
O'Dwyer, Michael [2 ,5 ,6 ]
Ryan, Aideen [1 ,2 ,3 ,4 ,6 ]
机构：
[1] NUI Galway, Sch Med, Coll Med,Nursing & Hlth Sci, Discipline Pharmacol & Therapeut, Galway, Ireland
[2] NUI Galway, Sch Med, Coll Med, Nursing & Hlth Sci, Galway, Ireland
[3] NUI Galway, Regenerat Med Inst REMEDI, Sch Med,Nursing & Hlth Sci, Coll Med, Galway, Ireland
[4] Galway Univ Hosp, Dept Hematol, Galway, Ireland
[5] Blood Canc Network Ireland, Galway, Ireland
[6] NUI Galway, SFI Res Ctr Med Devices, CURAM, Galway, Ireland
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-152432
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] GPRC5D as a novel immunotherapeutic target in multiple myeloma
    Nath, Karthik
    Costa, Bruno A.
    Mailankody, Sham
    NATURE REVIEWS CLINICAL ONCOLOGY, 2023, 20 (05) : 281 - 282
  • [42] STEM CELL MOBILIZATION EFFICIENCY OF HIGH DOSE CYCLOPHOSPHAMIDE COMPARED TO INTERMEDIATE DOSE CYCLOPHOSPHAMIDE IN MULTIPLE MYELOMA PATIENTS
    Colasante, F.
    Schiavo, D.
    Ferreri, A.
    Rinaldi, C.
    Savignano, C.
    Patriarca, F.
    Fanin, R.
    HAEMATOLOGICA, 2017, 102 : 135 - 135
  • [43] High-Dose Cyclophosphamide in Highly Refractory Multiple Myeloma Patients As a Bridge to Further Novel Therapies
    Nikonova, Anna
    Caplan, Stephen N.
    Shamy, April
    Gyger, Martin
    BLOOD, 2016, 128 (22)
  • [44] Elotuzumab: a novel anti-CS1 monoclonal antibody for the treatment of multiple myeloma
    Lonial, Sagar
    Kaufman, Jonathan
    Laubach, Jacob
    Richardson, Paul
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (12) : 1731 - 1740
  • [45] Low-dose thalidomide in combination with oral weekly cyclophosphamide and pulsed dexamethasone is a well tolerated and effective regimen in patients with relapsed and refractory multiple myeloma
    Kyriakou, C
    Thomson, K
    D'Sa, S
    Flory, A
    Hanslip, J
    Goldstone, AH
    Yong, KL
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (06) : 763 - 770
  • [46] Safety and efficacy of Elotuzumab combination therapy for patients with multiple myeloma: A systematic review and meta-analysis
    Noori, Maryam
    Fayyaz, Farimah
    Rezaei, Nima
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (03) : 327 - 338
  • [47] Phase II Trial of Combination of Elotuzumab, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma
    Liu, Chia-Jen
    Ghobrial, Irene M.
    Bustoros, Mark
    Reyes, Kaitlen
    Hornburg, Kalvis
    Badros, Ashraf Z.
    Vredenburgh, James J.
    Boruchov, Adam
    Matous, Jeffrey V.
    Caola, Aaron
    Rivotto, Bradley
    Savell, Alexandra
    Henrick, Patrick
    Paba-Prada, Claudia E.
    Schlossman, Robert L.
    Laubach, Jacob
    Rosenblatt, Jacalyn
    Yee, Andrew J.
    Nadeem, Omar
    Maegawa, Rodrigo O.
    Jakubowiak, Andrzej
    Usmani, Saad Z.
    Bhutani, Manisha
    Cappuccio, Joseph
    Berrios, Brianna
    Noonan, Kimberly
    Zavidij, Oksana
    Mouhieddine, Tarek H.
    Boehner, Cody J.
    Neuse, Carl-Jannes
    Salem, Karma Ziad
    Reidy, Mairead
    Park, Jihye
    Agius, Michael
    Rahmat, Mahshid
    Manier, Salomon
    Bhutani, Divaya
    Zonder, Jeffrey A.
    Munshi, Nikhil
    Auclair, Daniel
    Anderson, Kenneth
    Richardson, Paul
    BLOOD, 2018, 132
  • [48] Intermediate-dose cyclophosphamide and bortezomib for PBSC mobilization in multiple myeloma
    Sawazaki, Aiko
    Sugimori, Chiharu
    Yamaguchi, Masaki
    Nakao, Shinji
    TRANSFUSION AND APHERESIS SCIENCE, 2023, 62 (03)
  • [49] Primary chemotherapy of multiple myeloma with cyclophosphamide and high dose dexamethasone.
    Kim, CS
    Lee, MH
    Kim, I
    Lee, HB
    BLOOD, 2003, 102 (11) : 388B - 388B
  • [50] Frail elderly patients with relapsed-refractory multiple myeloma: efficacy and toxicity profile of the combination of bortezomib, high-dose dexamethasone, and low-dose oral cyclophosphamide
    Mele, Giuseppe
    Giannotta, Angela
    Pinna, Salvatore
    Loseto, Giacomo
    Coppi, Maria Rosaria
    Brocca, Claudio Maurizio
    Melpignano, Angela
    Quarta, Giovanni
    LEUKEMIA & LYMPHOMA, 2010, 51 (05) : 937 - 940
12345